awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q43848133-31DA854F-13FE-4DB3-BA41-7E9A39FB6401
Q43848133-31DA854F-13FE-4DB3-BA41-7E9A39FB6401
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43848133-31DA854F-13FE-4DB3-BA41-7E9A39FB6401
Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancer.
P2860
Q43848133-31DA854F-13FE-4DB3-BA41-7E9A39FB6401
BestRank
Statement
http://www.wikidata.org/entity/statement/Q43848133-31DA854F-13FE-4DB3-BA41-7E9A39FB6401
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
14164f50b55879da001ea4039327d699db5101d0
P2860
Cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in advanced ovarian cancer: a randomized phase III study of the National Cancer Institute of Canada Clinical Trials Group.